SCHEMBL7985534

SCHEMBL7985534

CCc1nc2ncn(CCCOc3ccccc3)c2c(=O)[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.44
CNOT7 Q9UIV1 1/20 0.44
LMNA P02545 4/20 0.43
MAPK1 P28482 3/20 0.43
POLB P06746 2/20 0.42
KDM4E B2RXH2 1/20 0.42
MPO P05164 1/20 0.42
TNKS2 Q9H2K2 1/20 0.41
KMT2A Q03164 3/20 0.41
ALOX15 P16050 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.40
MEN1 O00255 1/20 0.40
HPGD P15428 1/20 0.40
ALDH1A1 P00352 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985770 0.94 CNOT7 (0.50) L3MBTL1CNOT7LMNAMAPK1POLB
SCHEMBL7974261 0.85 LMNA (0.60) CNOT7LMNAMAPK1POLBKDM4E
SCHEMBL7974531 0.82 KDM4E (0.50) CNOT7LMNAMAPK1POLBKDM4E
SCHEMBL7985539 0.82 CNOT7 (0.52) L3MBTL1CNOT7LMNAMAPK1POLB
SCHEMBL7985444 0.78 CNOT7 (0.41) L3MBTL1CNOT7LMNAMAPK1POLB
SCHEMBL7987778 0.78 ALDH1A1 (0.51) L3MBTL1KDM4EKMT2ASMN1; SMN2MEN1
SCHEMBL7987233 0.77 LMNA (0.58) CNOT7LMNAMAPK1POLBKDM4E
SCHEMBL7985775 0.76 CNOT7 (0.58) L3MBTL1CNOT7LMNAMAPK1POLB
SCHEMBL7985079 0.74 KDM4E (0.49) CNOT7LMNAMAPK1POLBKDM4E
SCHEMBL7985536 0.74 SMN1; SMN2 (0.42) L3MBTL1CNOT7LMNAKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed